-
ESI-09
- names:
ESI-09
- CAS号:
263707-16-0
MDL Number: - MF(分子式): C16H15ClN4O2 MW(分子量): 330.77
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM000889-10mg | 10mg | 98.07% | ¥ 1641.60 | ¥ 1641.60 | 2-3天 | ¥ 0.00 | ||
| YZM000889-5mg | 5mg | 98.07% | ¥ 929.50 | ¥ 929.50 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | ESI-09 |
| CAS号 | 263707-16-0 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C16H15ClN4O2 |
| 分子量 Molecular Weight | 330.77 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度≥ 47 mg/mL(142.09 mM)H2O< 0.1 mg/mL(insoluble)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | ESI9 is a novel noncyclic nucleotideEPACantagonist withIC50values of 3.2 and 1.4 μM for EPAC1 and EPAC2, respectively. |
| Application1 | |
| Application2 | |
| Application3 |
ESI-09为新型非环状核苷酸EPAC的拮抗剂,抑制EPAC1 and EPAC2的IC50值分别为3.2和1.4 μM。ESI-09 is a novel noncyclic nucleotideEPACantagonist withIC50values of 3.2 and 1.4 μM for EPAC1 and EPAC2, respectively.
【1】.Almahariq M, et al. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol Pharmacol. 2013 Jan;83(1):122-8.
【2】.Gong B, et al. Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19615-20.
【2】.Gong B, et al. Exchange protein directly activated by cAMP plays a critical role in bacterial invasion during fatal rickettsioses. Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19615-20.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


